使用管状覆膜支架与近端凹槽覆膜支架血管内修复穿透性胸主动脉溃疡的比较
单中心回顾性队列研究纳入40例复杂穿透性主动脉溃疡患者,分别接受管状胸主动脉腔内修复(TEVAR)或凹槽TEVAR。凹槽组近端锚定区更近端(p=0.0001),两组临床成功率均为100%,再干预率分别为9.5%和5.3%,随访期间临床成功稳定,凹槽组发生1例腹部主动脉相关死亡。
要点
- 凹槽TEVAR组近端锚定区较管状TEVAR组更近端(p=0.0001)。
- 两组临床成功率均为100%,再干预率分别为9.5%和5.3%。
- 凹槽TEVAR可安全延长近端密封区以处理更近端病变。
核心结论
- 使用TEVAR及凹槽TEVAR治疗复杂穿透性主动脉溃疡均可提供优异且相似的临床成功、临床成功稳定性和主动脉生存率,并发症和再干预率可接受。
- 凹槽TEVAR可安全延长近端密封区以处理更近端病变。
研究设计与样本
- 单中心回顾性队列研究,纳入所有因复杂穿透性主动脉溃疡接受凹槽TEVAR和管状TEVAR治疗的非急性患者。
- 共审查212例TEVAR手术,纳入管状TEVAR组21例和凹槽TEVAR组19例,共40例患者。
主要发现
- 患者和穿透性主动脉溃疡特征相似,凹槽TEVAR组锚定区显著更近端(p=0.0001),两组主动脉上血管重建手术数量和类型相似。
- 全部40例患者(100%)达到临床成功,再干预率分别为管状TEVAR组2/21(9.5%)和凹槽TEVAR组1/19(5.3%)。
- 平均随访时间管状TEVAR组63个月、凹槽TEVAR组53个月,所有患者临床成功稳定,凹槽TEVAR组发生1例腹部主动脉相关死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In penetrating aortic ulcers (PAUs), limited data support tubular thoracic endovascular aortic repair (TEVAR) as a viable treatment option. For treatment of more proximal PAUs, hybrid approaches and-more recently-scalloped TEVAR (scTEVAR) have been advocated. Outcomes of scTEVAR specifically for PAUs have not yet been reported. This study reports long-term outcomes for tubular and scTEVAR in PAUs and compares the safety profile in both cohorts regarding the significantly more proximal landing zone (LZ) for scTEVAR. MATERIALS AND METHODS: This single-center retrospective cohort study includes all nonacute patients treated for complicated PAU with scTEVAR and tubular TEVAR. Patient and PAU characteristics as well as procedural success, complication and reintervention rates, and all-cause and aortic mortality were analyzed. RESULTS: Of 212 TEVAR procedures reviewed, 21 patients with tubular TEVAR and 19 patients with scTEVAR were included. Patient and PAU characteristics were similar, and LZ was significantly more proximal in the scTEVAR cohort (p=0.0001), with similar number and types of supra-aortic revascularization procedures. Clinical success was reached in all 40 patients (100%), and reintervention rate was 2/21 (9.5%) and 1/19 (5.3%), respectively. Over the mean follow-up of 63 (TEVAR) and 53 (scTEVAR) months, clinical success was stable in all patients with one (abdominal) aortic-related mortality in the scTEVAR cohort. CONCLUSION: Treatment of complicated PAUs with TEVAR as well as scTEVAR provides excellent and similar clinical success, stability of clinical success, and aortic survival with acceptable complication and reintervention rates. Scalloped TEVAR safely lengthens the proximal sealing zone to address more proximal pathologies. CLINICAL IMPACT: Treatment of asymptomatic complicated penetrating aortic ulcers (PAUs) with thoracic endovascular aortic repair (TEVAR) provides excellent clinical success and acceptable complication and reintervention rates. More patients become amenable to endovascular treatment by including scalloped TEVAR (scTEVAR) as a means to safely lengthen the proximal sealing zone to address more proximal pathologies.
引用
- Kupferthaler A, Hauck SR, Schwarz M, et al. Endovascular Repair of Penetrating Thoracic Aortic Ulcers Using Tubular Stent Grafts Versus Stent Grafts With a Proximal Scallop. J Endovasc Ther. 2023. PMID: 36680393. doi:10.1177/15266028221149919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。